SBTXSkinbiotherapeuticsSBTX info
$0.14info-0.94%24h
Global rank28628
Market cap$22.88M
Change 7d-11.37%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-8.08
P/S131.28
Revenue$174.32K
Earnings-$3.74M
Dividend yield-
Main Sector
Healthcare

Skinbiotherapeutics (SBTX) Stock Overview

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.

SBTX Stock Information

Symbol
SBTX
Address
The CoreNewcastle upon Tyne, NE4 5TFUnited Kingdom
Founded
-
Trading hours
8:00 AM - 4:30 PM GMT
Website
https://www.skinbiotherapeutics.com
Country
🇬🇧 United Kingdom
Phone Number
44 19 1495 7325

Skinbiotherapeutics (SBTX) Price Chart

-
Value:-

Skinbiotherapeutics Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.13893105587602467
N/A
Market Cap
$22.88M
N/A
Shares Outstanding
164.71M
5.06%
Employees
11.00
N/A
Shareholder Equity
1.99M
-19.41%
Valuation
2023
Change
P/E Ratio
-8.08
N/A
P/S Ratio
131.28
N/A
P/B Ratio
11.47
N/A
Growth
2023
Change
Return on Equity
-1.8753
N/A
Earnings
2023
Change
Revenue
$174.32K
N/A
Earnings
-$3.74M
N/A
EPS
-0.0172
N/A
Earnings Yield
-0.1238
N/A
Gross Margin
0.6451
N/A
Operating Margin
-22.45
N/A
Net income margin
-21.46
N/A
Financial Strength
2023
Change
Total Assets
$3.42M
N/A
Total Debt
$132.85K
N/A
Cash on Hand
$1.73M
N/A
Debt to Equity
0.3966
21.99%
Cash to Debt
$13.03
-7.66%
Current Ratio
$3.25
-29.12%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org